The ELISA test for human EG-VEGF/PROK1 allows the quantification of human EEG-VEGF in the human serum, plasma or cell culture medium. The dosage will recognize only natural and recombinant human EG-VEGF. Principle of...
The ELISA test for human EG-VEGF/PROK1 allows the quantification of human EEG-VEGF in the human serum, plasma or cell culture medium. The dosage will recognize only natural and recombinant human EG-VEGF. Method principle The ELISA solid phase sandwich test for human EG-VEGF (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
The vascular endothelial growth factor derived from the endocrine glands induces proliferation, migration and fenestration in the endothelial capillary cells derived from the endocrine glands. Its expression is induced by hypoxia and is limited to the steroidogenic glands. Its expression is often complementary to that of VEGF, suggesting that these molecules work in a coordinated manner.
Sensitivity
Sensitivity of dosage: 10 pg/ml.
Measurement range
Dose range: 13.72-10.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Intradose variation coefficient < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15445113 |
| Specifications |
| Accession number | P58294 |
| Dose range | 13.72-10.000 pg/ml |
| Sensitivity of the dosage | 10 pg/ml |
| Calibration range | 10 pg/ml to 10000 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Other proteins |
| Type of sample | Serum, Surnatant, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following tested cytokines: angiogenin, BDNF, BLC, CNTF, ENA- 78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, FGF-4, FGF-6, FGF-7, G-CSF, GDNF, G |
| Sufficient for | 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 84432 |
| Gene symbol(s) | PROK1 |
| Coefficient of inter-dose variation | < 12 % |
| Coefficient of intra-dose variation | < 10 % |
| Contents of kits | 96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Research disciplines | Angiogenesis |
| Synonym | UNQ600 / PRO1186, EGVEGF, PK1, PRK1 |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EHPROK1 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.